Cephalic Vein Cutdown Periprocedural Care

1. Hasan F, Nedios S, Karosiene Z, Scholten M, Lemke B, Tulka S, et al. Perioperative complications after pacemaker implantation: higher complication rates with subclavian vein puncture than with cephalic vein cutdown. J Interv Card Electrophysiol. 2022 Feb 2. [QxMD MEDLINE Link].

2. Anagnostopoulos I, Kossyvakis C, Kousta M, Verikokkou C, Lakka E, Karakanas A, et al. Different venous approaches for implantation of cardiac electronic devices. A network meta-analysis. Pacing Clin Electrophysiol. 2022 Jun. 45 (6):717-725. [QxMD MEDLINE Link].

3. Sarveswaran J, Burke D, Bodenham A. Cephalic vein cut-down verses percutaneous access: a retrospective study of complications of implantable venous access devices. Am J Surg. 2007 Nov. 194 (5):699. [QxMD MEDLINE Link]. [Full Text].

4. Tse HF, Lau CP, Leung SK. A cephalic vein cutdown and venography technique to facilitate pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol. 2001 Apr. 24 (4 Pt 1):469-73. [QxMD MEDLINE Link]. [Full Text].

5. Chang HM, Hsieh CB, Hsieh HF, Chen TW, Chen CJ, Chan DC, et al. An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. Eur J Surg Oncol. 2006 Feb. 32 (1):90-3. [QxMD MEDLINE Link].

6. Ussen B, Dhillon PS, Anderson L, Beeton I, Hickman M, Gallagher MM. Safety and feasibility of cephalic venous access for cardiac resynchronization device implantation. Pacing Clin Electrophysiol. 2011 Mar. 34 (3):365-9. [QxMD MEDLINE Link].

7. Ayadi S, Ksantini R, Maghrebi H, Daghfous A, Ayadi M, Fteriche F, et al. [Totally implantable venous access ports by cephalic vein cut-down for patients receiving chemotherapy]. Tunis Med. 2011 Aug-Sep. 89 (8-9):699-702. [QxMD MEDLINE Link].

8. Atti V, Turagam MK, Garg J, Koerber S, Angirekula A, Gopinathannair R, et al. Subclavian and Axillary Vein Access Versus Cephalic Vein Cutdown for Cardiac Implantable Electronic Device Implantation: A Meta-Analysis. JACC Clin Electrophysiol. 2020 Jun. 6 (6):661-671. [QxMD MEDLINE Link].

9. Benz AP, Vamos M, Erath JW, Hohnloser SH. Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis. Europace. 2019 Jan 1. 21 (1):121-129. [QxMD MEDLINE Link].

10. Klaiber U, Probst P, Hackbusch M, Jensen K, Dörr-Harim C, Hüttner FJ, et al. Meta-analysis of primary open versus closed cannulation strategy for totally implantable venous access port implantation. Langenbecks Arch Surg. 2021 May. 406 (3):587-596. [QxMD MEDLINE Link].

11. Loukas M, Myers CS, Wartmann ChT, Tubbs RS, Judge T, Curry B, et al. The clinical anatomy of the cephalic vein in the deltopectoral triangle. Folia Morphol (Warsz). 2008 Feb. 67 (1):72-7. [QxMD MEDLINE Link].

12. Chen JY, Chang KC, Lin YC, Chou HT, Hung JS. Feasibility and accuracy of pre-procedure imaging of the proximal cephalic vein by duplex ultrasonography in pacemaker and defibrillator implantation. J Interv Card Electrophysiol. 2004 Feb. 10 (1):31-5. [QxMD MEDLINE Link]. [Full Text].

13. Chen JY, Chang KC, Lin YC, Chou HT, Hung JS. Pre-procedure duplex ultrasonography to assist cephalic vein isolation in pacemaker and defibrillator implantation. J Interv Card Electrophysiol. 2005 Jan. 12 (1):75-81. [QxMD MEDLINE Link]. [Full Text].

14. Otsubo R, Hatachi T, Shibata K, Yoshida T, Watanabe H, Oikawa M, et al. Evaluation of totally implantable central venous access devices with the cephalic vein cut-down approach: Usefulness of preoperative ultrasonography. J Surg Oncol. 2016 Jan. 113 (1):114-9. [QxMD MEDLINE Link].

15. Lau EW, Liew R, Harris S. An unusual case of the cephalic vein with a supraclavicular course. Pacing Clin Electrophysiol. 2007 May. 30 (5):719-20. [QxMD MEDLINE Link]. [Full Text].

16. Knight BP, Curlett K, Oral H, Pelosi F, Morady F, Strickberger SA. Clinical predictors of successful cephalic vein access for implantation of endocardial leads. J Interv Card Electrophysiol. 2002 Oct. 7 (2):177-80. [QxMD MEDLINE Link]. [Full Text].

17. Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol. 2005 Jun. 13 (1):9-19. [QxMD MEDLINE Link]. [Full Text].

18. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace. 2007 May. 9 (5):328-32. [QxMD MEDLINE Link]. [Full Text].

19. Faraj W, Selmo F, Hindi M, Haddad F, Khalil I. Cephalic vein aneurysm. Ann Vasc Surg. 2007 Nov. 21 (6):804-6. [QxMD MEDLINE Link]. [Full Text].

20. Romeyer-Bouchard C, Da Costa A, Abdellaoui L, Messier M, Thévenin J, Afif Z, et al. Simplified cardiac resynchronization implantation technique involving right access and a triple-guide/single introducer approach. Heart Rhythm. 2005 Jul. 2 (7):714-9. [QxMD MEDLINE Link]. [Full Text].

21. Neri R, Cesario AS, Baragli D, Monti F, Danisi N, Glaciale G, et al. Permanent pacing lead insertion through the cephalic vein using an hydrophilic guidewire. Pacing Clin Electrophysiol. 2003 Dec. 26 (12):2313-4. [QxMD MEDLINE Link]. [Full Text].

22. LeDonne J. Percutaneous cephalic vein cannulation (in the Deltopectoral Groove), with ultrasound guidance. J Am Coll Surg. 2005 May. 200 (5):810-1. [QxMD MEDLINE Link]. [Full Text].

23. Jung KH, Moon SB. Cephalic vein cutdown for totally implantable central venous port in children: a retrospective analysis of prospectively collected data. Can J Surg. 2014 Feb. 57 (1):21-5. [QxMD MEDLINE Link].

24. Kircanski B, Vasic D, Savic D, Stojanov P. Low incidence of complications after cephalic vein cutdown for pacemaker lead implantation in children weighing less than 10 kilograms: A single-center experience with long-term follow-up. Heart Rhythm. 2015 Aug. 12 (8):1820-6. [QxMD MEDLINE Link].

Adam S Budzikowski, MD, PhD, FHRS Assistant Professor of Medicine, Division of Cardiovascular Medicine, Electrophysiology Section, State University of New York Downstate Medical Center, University Hospital of Brooklyn

Adam S Budzikowski, MD, PhD, FHRS is a member of the following medical societies: European Society of Cardiology, Heart Rhythm Society

Disclosure: Received consulting fee from Boston Scientific for speaking and teaching; Received honoraria from St. Jude Medical for speaking and teaching; Received honoraria from Zoll for speaking and teaching.

Ethan Levine, DO Director of Cardiac Electrophysiology, Arnot Ogden Medical Center

Ethan Levine, DO is a member of the following medical societies: American College of Cardiology, American Heart Association, Heart Rhythm Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Vincent Lopez Rowe, MD, FACS Professor and Chief, Division of Vascular and Endovascular Surgery, Gonda (Goldschmied) Vascular Center, University of California, Los Angeles, David Geffen School of Medicine

Vincent Lopez Rowe, MD, FACS is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association of Program Directors in Vascular Surgery, Los Angeles Surgical Society, Pacific Coast Surgical Association, Society for Clinical Vascular Surgery, Society for Vascular Surgery, Society of Black Academic Surgeons, Society of Black Vascular Surgeons, Southern California Vascular Surgical Society, Western Vascular Society

Disclosure: Nothing to disclose.

Luis M Lovato, MD Associate Clinical Professor, University of California, Los Angeles, David Geffen School of Medicine; Director of Critical Care, Department of Emergency Medicine, Olive View-UCLA Medical Center

Luis M Lovato, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article